KAVANAGH SARAH B 4
4 · Valeant Pharmaceuticals International, Inc. · Filed May 4, 2018
Insider Transaction Report
Form 4
KAVANAGH SARAH B
Director
Transactions
- Award
Common Stock, No Par Value
2018-05-03+14,285→ 54,149 total
Footnotes (1)
- [F1]Represents the award of restricted share units ("RSUs") granted to non-employee directors of Valeant Pharmaceuticals International, Inc. ("Valeant") on the third business day following their election at the Annual Meeting of Shareholders of Valeant (the "Annual Meeting"). The RSUs have a grant date value equal to $250,000, vest immediately prior to Valeant's next Annual Meeting, and are settled in common shares, no par value, of Valeant.